Use of Tyrosine Kinase Inhibitors (TKIs)

Basic Details
Date Posted
Tuesday, February 27, 2018
Status
Complete
Medical Product
axitinib
pazopanib
sorafenib
sunitinib
tyrosine kinase inhibitor
Description

These reports contain baseline characteristics of patients receiving four types of tyrosine kinase inhibitors (TKIs) in the Sentinel Distributed Database (SDD). This request was distributed to 16 Data Partners on August 23, 2016; this report contains data from 16 Data Partners.

Deliverables (3)
Sentinel Modular Program Report: Tyrosine Kinase Inhibitors Report 1 Sentinel Modular Program Report: Tyrosine Kinase Inhibitors Report 2 Sentinel Modular Program Report: Tyrosine Kinase Inhibitors Report 3
Additional Details
FDA Center
CDER
Time Period
January 1, 2006 - September 30, 2015
Study Type
Modular Program
Assessment Type
Exploratory Analyses
Population / Cohort
Individuals 18 years of age and older
Data Sources
Sentinel Distributed Database (SDD)